PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 136 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2019. The put-call ratio across all filers is 1.14 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $12,573,000 | -11.7% | 1,246,121 | -8.7% | 2.28% | +64.4% |
| Q2 2020 | $14,241,000 | +110.9% | 1,365,376 | +70.7% | 1.38% | +46.0% |
| Q1 2020 | $6,752,000 | +120.9% | 800,000 | +129.0% | 0.95% | +159.7% |
| Q4 2019 | $3,057,000 | -18.7% | 349,400 | 0.0% | 0.36% | -43.2% |
| Q3 2019 | $3,761,000 | -15.3% | 349,400 | 0.0% | 0.64% | +7.2% |
| Q2 2019 | $4,441,000 | -67.2% | 349,400 | 0.0% | 0.60% | -76.0% |
| Q1 2019 | $13,553,000 | +169.2% | 349,400 | +41.2% | 2.50% | +116.2% |
| Q4 2018 | $5,035,000 | – | 247,400 | – | 1.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 1,792,114 | $4,713,260 | 4.15% |
| Eversept Partners, LP | 1,681,149 | $4,421,422 | 0.37% |
| Camber Capital Management LP | 4,235,000 | $11,138 | 0.37% |
| Kynam Capital Management, LP | 473,975 | $1,246,554 | 0.20% |
| GLOBEFLEX CAPITAL L P | 538,559 | $1,416,410 | 0.17% |
| Affinity Asset Advisors, LLC | 202,349 | $532,178 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 279,629 | $735 | 0.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 363,666 | $956,442 | 0.06% |
| Patriot Financial Group Insurance Agency, LLC | 67,000 | $176,210 | 0.04% |
| ACADIAN ASSET MANAGEMENT LLC | 1,858,000 | $4,884 | 0.02% |